We are live on ! Find out more
DLA

Douglas Lane & Associates Portfolio holdings

AUM $7.37B
1-Year Est. Return 21.9%
This Fund
S&P 500
This Quarter Est. Return
+10.43%
1 Year Est. Return
+21.9%
3 Year Est. Return
+71.89%
5 Year Est. Return
+87.03%
10 Year Est. Return
+444.88%
AUM
$5.38B
AUM Growth
+$356M
Cap. Flow
-$95.3M
Cap. Flow %
-1.77%
Top 10 Hldgs %
22.08%
Holding
225
New
6
Increased
74
Reduced
113
Closed
13

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$41.5M
2
SLB icon
SLB Ltd
SLB
+$19.4M
3
GSK icon
GSK
GSK
+$15.1M
4
EOG icon
EOG Resources
EOG
+$10.5M
5
APA icon
APA Corp
APA
+$9M

Top Sells

Rank Stock Value
1
PPLI
People Inc
PPLI
+$80.1M
2
CELG
Celgene Corp
CELG
+$72.6M
3
BWA icon
BorgWarner
BWA
+$26.4M
4
EXPE icon
Expedia Group
EXPE
+$26.1M
5
XRAY icon
Dentsply Sirona
XRAY
+$19.3M

Sector Composition

Rank Sector Weight
1 Financials 23.04%
2 Technology 14.53%
3 Industrials 13.46%
4 Healthcare 13.02%
5 Consumer Discretionary 8.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
QCOM icon
1
Qualcomm
QCOM
$160B
$139M 2.59%
1,577,101
-36,232
-2% -$3.03M
MSFT icon
2
Microsoft
MSFT
$3.35T
$133M 2.47%
840,909
-23,121
-3% -$3.4M
BMY icon
3
Bristol-Myers Squibb
BMY
$132B
$132M 2.46%
2,056,901
+724,940
+54% +$41.5M
JPM icon
4
JPMorgan Chase
JPM
$933B
$121M 2.26%
871,385
-3,274
-0.4% -$420K
ILMN icon
5
Illumina
ILMN
$31B
$121M 2.24%
373,980
-1,765
-0.5% -$535K
DAL icon
6
Delta Air Lines
DAL
$58.3B
$119M 2.21%
2,028,424
+19,165
+1% +$1.07M
V icon
7
Visa
V
$673B
$112M 2.08%
595,302
-16,301
-3% -$2.94M
FRC
8
DELISTED
First Republic Bank
FRC
$106M 1.97%
899,882
+1,853
+0.2% +$200K
TMO icon
9
Thermo Fisher Scientific
TMO
$214B
$103M 1.92%
318,544
-5,536
-2% -$1.68M
MA icon
10
Mastercard
MA
$510B
$101M 1.89%
339,572
-14,370
-4% -$4.05M
GM icon
11
General Motors
GM
$80B
$98.3M 1.83%
2,686,576
+46,135
+2% +$1.68M
EQIX icon
12
Equinix
EQIX
$103B
$96.2M 1.79%
164,836
-3,504
-2% -$1.97M
USB icon
13
US Bancorp
USB
$98B
$92.2M 1.71%
1,555,044
+1,024
+0.1% +$59.2K
PRU icon
14
Prudential Financial
PRU
$42.6B
$91.2M 1.7%
973,125
+31,976
+3% +$2.94M
DHR icon
15
Danaher
DHR
$138B
$85.5M 1.59%
628,011
-6,210
-1% -$785K
APTV icon
16
Aptiv
APTV
$12.3B
$84.4M 1.57%
889,216
-8,670
-1% -$794K
GOOG icon
17
Alphabet (Google) Class C
GOOG
$4.08T
$82.4M 1.53%
1,233,100
-42,560
-3% -$2.75M
NVDA icon
18
NVIDIA
NVDA
$4.72T
$82.1M 1.53%
13,962,280
+4,800
+0% +$25K
BX icon
19
Blackstone
BX
$102B
$81.5M 1.52%
1,457,347
+78,061
+6% +$4.05M
FBIN icon
20
Fortune Brands Innovations
FBIN
$5.88B
$80.8M 1.5%
1,446,636
-43,856
-3% -$2.31M
TFC icon
21
Truist Financial
TFC
$63.5B
$80.5M 1.5%
1,429,013
+1,539
+0.1% +$83.3K
BAC icon
22
Bank of America
BAC
$433B
$78.9M 1.47%
2,241,370
+14,209
+0.6% +$459K
DISCK
23
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
$78.8M 1.46%
2,583,140
+32,160
+1% +$902K
LOW icon
24
Lowe's Companies
LOW
$118B
$78.5M 1.46%
655,230
+2,279
+0.3% +$261K
ORCL icon
25
Oracle
ORCL
$367B
$77.8M 1.45%
1,467,822
+2,010
+0.1% +$111K
1
2 3 4 5

Similar funds

BIM
Bridges Investment Management Omaha, Nebraska $7.38B AUM 15.39% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
KWM
Kingsview Wealth Management Grants Pass, Oregon $7.33B AUM 16.07% 1-Year Est. Return
GLF
Groupe la Francaise Paris, France $7.29B AUM 37.28% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $7.5B AUM 22.48% 1-Year Est. Return
ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Douglas Lane & Associates's Q4 2019 Portfolio in Review

As of Q4 2019, Douglas Lane & Associates held 225 positions worth $5.38B, up 7.1% from $5.02B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Douglas Lane & Associates's Q4 2019 filing shows 6 new, 74 increased, 113 reduced and 13 closed positions. Its largest new stake was Elanco Animal Health: 120,472 shares worth $3.55M. The largest sale was People Inc, an estimated $80.1M.

By sector, the portfolio is most concentrated in Financials at 23% of assets, up from 23% a quarter earlier, followed by Technology and Industrials.

  • Douglas Lane & Associates's largest Q4 2019 buy was Elanco Animal Health: 120,472 shares worth $3.55M.
  • Douglas Lane & Associates added most to Bristol-Myers Squibb in Q4 2019, an estimated $41.5M increase.
  • Douglas Lane & Associates's biggest Q4 2019 reduction was People Inc, cutting an estimated $80.1M.
  • Douglas Lane & Associates fully exited Celgene Corp in Q4 2019, selling an estimated $72.6M.
  • Douglas Lane & Associates's ten largest holdings make up 22% of its $5.38B portfolio in Q4 2019.
  • Douglas Lane & Associates opened 6 new positions and closed 13 in Q4 2019.
  • Douglas Lane & Associates's portfolio value rose 7.1% quarter-over-quarter to $5.38B.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.